Amylyx Pharmaceuticals
The Senior Director, Safety Physician provides medical and scientific leadership for the evaluation of safety profiles and benefit-risk assessments for investigational and commercial products. This role involves overseeing safety data throughout the product lifecycle, from clinical development to post-marketing surveillance, while ensuring compliance with global pharmacovigilance regulations. The position requires close collaboration with cross-functional teams to support regulatory submissions, risk management, and safety governance.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
21% above the average for this role
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Director, Drug Safety & Pharmacovigilance Scientist
Dyne Therapeutics
Global Pharmacovigilance Medical Director
Beeline Medicines
Medical Director, Patient Safety Physician
AstraZeneca
Senior Director, Global Safety Physician
Madrigal Pharmaceuticals
Safety MD Senior Director
Bristol Myers Squibb
Safety Aggregate Report & Analytics (SARA) Specialist 2
IQVIA